Stay updated on Nivolumab in IDH-Mutant Gliomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in IDH-Mutant Gliomas Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    An NIH notice about its website transition and updated terminology appears above the page, while the clinical trial record still displays a 403 Forbidden error. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:30:03.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision number was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:36:52.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Removed the 403 Forbidden error screen HTML and related elements, addressing a core access issue that previously blocked viewing the study details. This change suggests the page can render the study details normally without displaying an error screen.
    Difference
    0.5%
    Check dated 2026-09-30T00:46:11.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a basic header and a Home link, and a large set of study-related documents and metadata are removed from the listing.
    Difference
    20%
    Check dated 2026-09-23T00:37:34.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This reflects an update to the page's revision history template rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-09-15T23:58:11.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.6, replacing v3.6.5. This indicates a small version update in the site's backend or UI without changing the study content shown.
    Difference
    0.1%
    Check dated 2026-09-01T20:56:27.000Z thumbnail image

Stay in the know with updates to Nivolumab in IDH-Mutant Gliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.